Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High transmissibility of COVID-19 near symptom onset

Hao-Yuan Cheng, Shu-Wan Jian, Ding-Ping Liu, View ORCID ProfileTa-Chou Ng, Wan-Ting Huang, for Taiwan COVID-19 outbreak investigation team, View ORCID ProfileHsien-Ho Lin
doi: https://doi.org/10.1101/2020.03.18.20034561
Hao-Yuan Cheng
1Epidemic Intelligence Center, Taiwan Centers for Disease Control
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu-Wan Jian
1Epidemic Intelligence Center, Taiwan Centers for Disease Control
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ding-Ping Liu
1Epidemic Intelligence Center, Taiwan Centers for Disease Control
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ta-Chou Ng
3Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ta-Chou Ng
Wan-Ting Huang
2Office of Preventive Medicine, Taiwan Centers for Disease Control
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsien-Ho Lin
3Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hsien-Ho Lin
  • For correspondence: hsienho@ntu.edu.tw
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The dynamics of coronavirus disease 2019 (COVID-19) transmissibility after symptom onset remains unknown.

Methods We conducted a prospective case-ascertained study on laboratory-confirmed COVID-19 cases and their contacts. Secondary clinical attack rate (considering symptomatic cases only) was analyzed for different exposure windows after symptom onset of index cases and for different exposure settings.

Results Thirty-two confirmed patients were enrolled and 12 paired data (index-secondary cases) were identified among the 1,043 contacts. The secondary clinical attack rate was 0.9% (95% CI 0.5–1.7%). The attack rate was higher among those whose exposure to index cases started within five days of symptom onset (2.4%, 95% CI 1.1–4.5%) than those who were exposed later (zero case from 605 close contacts, 95% CI 0–0.61%). The attack rate was also higher among household contacts (13.6%, 95% CI 4.7–29.5%) and non- household family contacts (8.5%, 95% CI 2.4–20.3%) than that in healthcare or other settings. The higher secondary clinical attack rate for contacts near symptom onset remained when the analysis was restricted to household and family contacts. There was a trend of increasing attack rate with the age of contacts (p for trend < 0.001).

Conclusions High transmissibility of COVID-19 near symptom onset suggests that finding and isolating symptomatic patients alone may not suffice to contain the epidemic, and more generalized social distancing measures are required. Rapid reduction of transmissibility over time implies that prolonged hospitalization of mild cases might not be necessary in large epidemics.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was funded by Taiwan Ministry of Science and Technology (MOST 107-2314-B-002-187-MY2, and MOST 108-2628-B-002-022). The funder of this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data is available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 19, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High transmissibility of COVID-19 near symptom onset
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High transmissibility of COVID-19 near symptom onset
Hao-Yuan Cheng, Shu-Wan Jian, Ding-Ping Liu, Ta-Chou Ng, Wan-Ting Huang, for Taiwan COVID-19 outbreak investigation team, Hsien-Ho Lin
medRxiv 2020.03.18.20034561; doi: https://doi.org/10.1101/2020.03.18.20034561
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
High transmissibility of COVID-19 near symptom onset
Hao-Yuan Cheng, Shu-Wan Jian, Ding-Ping Liu, Ta-Chou Ng, Wan-Ting Huang, for Taiwan COVID-19 outbreak investigation team, Hsien-Ho Lin
medRxiv 2020.03.18.20034561; doi: https://doi.org/10.1101/2020.03.18.20034561

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (221)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)